1. Biotechnology In India —An Introduction
2. Biotech Sector in India: Changing Legal Framework
2.1 Fiscal Incentives provided to the Biotech Sector
2.2 Important Changes To The Patents Act Proposed In The Third Amendment Bill
2.3 Plant Varieties And Farmers’ Rights Protection Act, 2001
2.4 Other Regulations Impacting The Biotech Sector
2.4.1 Licensing
2.4.2 Clinical Trials
2.4.3 Seeds Act And Policy
2.4.4 Environmental Clearances
2.4.5 Biodiversity
2.5 Status On Enforcement
3. Bio-Clusters: State Driven Initiatives And Policies
3.1 Southern Region
3.2 Western Region
3.3 Northern Region
4. Indian Biotechnology Market Analysis, 2005
4.1 Total Market Size, (%) 2005
4.2 Growth Forecasts for the Indian Biotechnology Industry ($ Million), 2007-2010
4.3 Market Size By Industry Segments, (%) 2005
4.3.1 Biopharmaceuticals
4.3.2 Bioinformatics
4.3.3 Industrial Biotech
4.3.4 Agri Biotech
4.3.5 Bioservices (Contract Research)
4.3.6 Employment In Indian Biotech Industry, (%)
4.4 Biotech Exports, By Segment-Wise, (%) 2005
4.4.1 Biotech Suppliers
4.5 Number Of Companies And Associations, (In Numbers) 2005
4.6 Employment Opportunities In India
4.7 Investments In Indian Biotechnology Sector, 2005
4.8 Status Of Biotech Parks In India
5. SWOT Analysis Of Indian Biotechnology Sector
6. India Biotechnology Industry And Outsourcing Opportunities
7. India’s Biotechnology Research And Development Strengths
8. India's New Draft National Biotechnology Development Strategy— Geared Towards Encouraging Public-Private Partnership
9. Key Industry Trends And Opportunities In Indian Biotech Industry
10. Strategies For The Indian Biotech Industry Future
10.1 Generate National Level Resource Strength In Bioinformatics
10.2 Promote R&D Strengths
10.3 Promote Entrepreneurial Development
10.4 Globalization Of The National Bioinformatics Initiatives
10.5 Encourage Human Resource Development, Education, & Awareness
10.6 Restructuring Of The BTIS Organization For Optimized Performance
11. Financial Strategy for Emerging Bio-Companies
12. Company Profiles Of Key Players
12.1 Biocon
12.2 Serum Institute Of India
12.3 Panacea Biotech
12.4 Nicholas Piramal
12.5 Wockhardt Limited
12.6 Glaxosmithkline
12.7 Bharat Serums
12.8 Krebs Biochemical’s & Industries Limited
12.9 Indian Immunologicals
12.10 Zydus Cadila
12.11 Shantha Biotechnics
12.12 Biological E
12.13 Chiron Behring Vaccines
12.14 Eli Lilly And Company
12.15 Novo Nordisk
12.16 Mahyco Monsanto
12.17 Bharat Biotech
12.18 Abbott
12.19 Ranbaxy
12.20 Novozymes